Quest Diagnostics (DGX) Accumulated Expenses (2010 - 2025)

Quest Diagnostics has disclosed Accumulated Expenses across 14 years of filings, most recently posting $338.0 million for Q4 2025.

• In Q4 2025, Accumulated Expenses rose 10.46% year-over-year to $338.0 million; the TTM figure through Dec 2025 stood at $338.0 million (up 10.46% YoY), while the FY2025 annual figure was $338.0 million, up 10.46% from the prior year.
• Accumulated Expenses came in at $338.0 million for Q4 2025 at Quest Diagnostics, up from $306.0 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $460.0 million in Q4 2021 to a low of $287.0 million in Q4 2023.
• Average Accumulated Expenses over 5 years is $356.6 million, with a median of $338.0 million recorded in 2025.
• Year-over-year, Accumulated Expenses rose 29.21% in 2021 and dropped 26.79% in 2023.
• Over 5 years, Accumulated Expenses stood at $460.0 million in 2021, then fell by 14.78% to $392.0 million in 2022, then slipped by 26.79% to $287.0 million in 2023, then grew by 6.62% to $306.0 million in 2024, then grew by 10.46% to $338.0 million in 2025.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $338.0 million in Q4 2025, $306.0 million in Q4 2024, and $287.0 million in Q4 2023.